Automated echocardiography analysis, including cardiac amyloidosis detection.
FDA cleared and CE marked for the cardiac amyloidosis detection module.
Vendor press release for the clearance/marking.
Not found in this research pass — verify before publishing.
Partnership with Aidoc to integrate echo AI into the aiOS platform; no independent site count found.
No independent evidence found in this pass.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.